Product
Technetium Tc-99m Sodium Pertechnetate
1 clinical trial
10 indications
Indication
Endometrial CarcinomaIndication
Recurrent Endometrial AdenocarcinomaIndication
Endometrial CancerIndication
Endometrial Clear Cell AdenocarcinomaIndication
Endometrial Endometrioid AdenocarcinomaIndication
Endometrial Mixed Cell AdenocarcinomaIndication
Endometrial Undifferentiated CarcinomaIndication
Recurrent Uterine Corpus CarcinosarcomaIndication
Stage IV Uterine Corpus Cancer AJCC v7Clinical trial
Phase I Trial of Intravenous Administration of Vesicular Stomatitis Virus Genetically Engineered to Express Thyroidal Sodium Iodide Symporter (NIS) and Human Interferon Beta (hIFNb), in Patients With Metastatic or Recurrent Endometrial CancerStatus: Active (not recruiting), Estimated PCD: 2024-06-01